Emily Louise Livelsberger LGPC

Recommended Articles

• Everything You Need to Know About a Hysterectomy

  Within the pelvic cavity, two ovaries connect via the fallopian tubes to the centrally positioned uterus, creating the female reproductive system. These organs produce female growth hormones, release ova (eggs), control the menstrual cycle, and oversee pregnancy, gestation, and the birth of a baby....

• Can ADHD Be Treated Only with Medication?

  Medication alone isn’t enough. Medication for ADHD is not all about seeking the services of a doctor or physician. You need to design mechanisms you can use to tackle the challenges associated with ADHD so that you can lead a more peaceful and productive life. With the most reliable tips, you can...

• How Is Hepatitis C Transmitted?

  Hepatitis CHepatitis C causes inflammation of the liver. The incubation period of the hepatitis C virus is 6-7 weeks. After the incubation period, symptoms begin to show. However, approximately 80 percent of people with acute hepatitis may show no symptoms. Other types of hepatitis are hepatitis A...

• How is Sinusitis Diagnosed?

  Sinus infection or sinusitis can be diagnosed by a qualified medical practitioner after a series of tests and examinations. Most cases are actually diagnosed based on the medical history of the patient and the examination of the doctor. This is because the more effective procedures like the MRI and...

• Nutritionist and Nutrition Counseling: Do We Need These?

  What is a nutritionist and what is nutrition counseling?Nutritionist:A medical professional who helps design and modify one's diet in accordance with any illness an individual may have.Nutrition counseling: A continuous counseling process in which a nutritionist delivers various dietary...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...